Common single nucleotide polymorphisms in the FNDC5 gene and serum irisin levels in acute myocardial infarction

Acute myocardial infarction (AMI) is the most common type of coronary artery disease. The irisin hormone encoded by the fibronectin type III domain-containing protein-5 (FNDC5) gene is synthesized in muscle, heart, and fat tissues. The present study aims to investigate serum irisin concentrations an...

Full description

Saved in:
Bibliographic Details
Published in:Anatolian journal of cardiology 2021-08, Vol.25 (8), p.528-535
Main Authors: Önalan Etem, Ebru, Diş, Özge, Tektemur, Ahmet, Korkmaz, Hasan, Buran Kavuran, İlay
Format: Article
Language:English
Subjects:
Case-Control Studies
Fibronectins - genetics
Gene Frequency
Genotype
Humans
Male
Myocardial Infarction - genetics
Original Investigation
Polymorphism, Single Nucleotide
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Acute myocardial infarction (AMI) is the most common type of coronary artery disease. The irisin hormone encoded by the fibronectin type III domain-containing protein-5 (FNDC5) gene is synthesized in muscle, heart, and fat tissues. The present study aims to investigate serum irisin concentrations and FNDC5 genetic variants in patients with AMI through comparison with controls. This study included 225 patients with AMI and 225 healthy subjects. Blood samples were obtained from patients during the first 1-24 hours after AMI. Serum irisin concentration was measured with enzyme-linked immunosorbent assay (ELISA). The variants of rs16835198, rs3480, and rs726344 in the FNDC5 gene were genotyped with real time polymerase chain reaction (RT-PCR). Compared with control serum irisin concentrations were significantly lower in patients with AMI. Serum irisin concentrations of patients with AMI showed a significant and gradual decrease from 6 hours up to 24 hours (p0.05). However, the frequency of the TT genotype in male patients with AMI (6.4%) was significantly lower compared with control male subjects (16.2%). In addition, the GGT haplotype was identified as the protective haplotype against the risk of AMI (p
ISSN:2149-2263
2149-2271
DOI:10.5152/AnatolJCardiol.2021.36214